CFD simulation and validation of flow in small arteries to enable further drug delivery studies
Revista Facultad de Ingenieria, ISSN: 2422-2844, Issue: 97, Page: 78-86
2020
- 1Citations
- 199Usage
- 13Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Treatments based on nanocarriers such as nanoparticles have emerged as alternatives to overcome common limitations and side effects caused by traditional treatments against cancer and neurological diseases. The main attribute of nanoparticles stems from the fact that they can transport pharmacological agents in a guided manner. This allows drugs to selectively target diseased rather than healthy tissues. This work was aimed at modeling and simulating fluid flow inside small arteries and experimentally validating the model through quantitative measurements of pressure and flow rates. The validity of the model was evaluated in the light of different indexes of percentage agreement between simulated and measured values. The model was previously verified via mesh convergence analysis and qualitative observations of velocity profile. Our findings provide a robust basis for studying nanoparticle transport in arteries as the developed platform enables their releasing and remote manipulation both in silico and in vitro.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85087075119&origin=inward; http://dx.doi.org/10.17533/udea.redin.20191257; https://revistas.udea.edu.co/index.php/ingenieria/article/view/328519; http://aprendeenlinea.udea.edu.co/revistas/index.php/ingenieria/article/viewFile/328519/20795452; http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-62302020000400078&lng=en&tlng=en; http://www.scielo.org.co/scielo.php?script=sci_abstract&pid=S0120-62302020000400078&lng=en&tlng=en; http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-62302020000400078; http://www.scielo.org.co/scielo.php?script=sci_abstract&pid=S0120-62302020000400078; https://zenodo.org/record/3857874; https://dx.doi.org/10.17533/udea.redin.20191257
Universidad de Antioquia
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know